However, in late-onset AD, iTRAQ data showed marginal down-regulation of NDUFA4 and NDUFA9 (Fig. 5a), western blot analysis (Fig. 5b-d) did not revealed significant alterations. The gene discussed is NDUFA9; the disease is Alzheimer disease.